Search - tctmd.com

Displaying 141 - 160 of 281

Sort: Relevancy | Date

News Conference News ESC 2017

Dual Antithrombotic Approach in Patients With A-fib Undergoing PCI Boosted in RE-DUAL PCI

Todd Neale

August 27, 2017

News Conference News ESC 2017

ESC Updates Guidelines for Treating STEMI Patients

Michael O'Riordan

August 27, 2017

News Conference News ESC 2017

CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events

Michael O'Riordan

August 27, 2017

News Industry News

Study Results: Titaniam-nitride-oxide (TiNO) Coated Stent is Non-inferior to Bioabsorbable Polymer Everolimus-eluting Stent (EES), for Patients Presenting with Acute Coronary Syndrome (ACS)

August 26, 2017

News Conference News ESC 2017

CABG Appears Superior to PCI for Patients With Type 1 Diabetes, Multivessel Disease

Todd Neale

August 26, 2017

News Daily News

Off-Pump CABG Linked to Higher Long-term Mortality in ROOBY-FS

L.A. McKeown

August 16, 2017

Presentation CHIP Seattle 2017

Revascularization in Shock: Does it matter?

Presenter: Robert W. Yeh

August 11, 2017

Presentation CHIP Seattle 2017

When to Use Support for Complete Revascularization

Presenter: Ajay J. Kirtane

August 11, 2017

Presentation CHIP Seattle 2017

Inotropes and Drug Therapies for Shock: Data and Outcomes

Presenter: Sunil V. Rao

August 11, 2017

Presentation CHIP Seattle 2017

Unprotected Left Main Stenting and Complete Revascularization

Presenter: Paul Teirstein

August 11, 2017

Presentation CHIP Seattle 2017

The Case for Complete Revascularization

Presenter: Robert F. Riley

August 10, 2017

Presentation CHIP Seattle 2017

Yes, the Data Favor Invasive Management and Revascularization for These Patients (with Ischemic CM)

Presenter: Ajay J. Kirtane

August 10, 2017

News Daily News

Readmissions After Acute MI Not Only Confined to the Elderly

Yael L. Maxwell

August 09, 2017

News Daily News

Money-Back Guarantee for Evolocumab Has Little Impact on Cost-Effectiveness

Michael O'Riordan

August 08, 2017

News Daily News

CKD Patients Undergoing PCI Much Less Likely to Receive Potent P2Y12 Inhibition

Michael O'Riordan

August 04, 2017

News Daily News

Registry Confirms Long-term Durability of Drug-Coated Balloon for Femoropopliteal Lesions

L.A. McKeown

August 03, 2017

News Daily News

‘Remnant’ Cholesterol Linked With CVD Risk, Even When LDL Levels Are Low

Michael O'Riordan

August 01, 2017

News Daily News

Despite the Strengths of Next-Gen DES, BMS Deserve a Place at the Cath Table, Review Asserts

Caitlin E. Cox

July 28, 2017

News Industry News

Spectranetics Announces FDA Approval of Stellarex™ Drug-Coated Balloon

July 27, 2017

News Industry News

Spectranetics Announces FDA Approval of Stellarex™ Drug-Coated Balloon

July 26, 2017

Advertisement

Dual Antithrombotic Approach in Patients With A-fib Undergoing PCI Boosted in RE-DUAL PCI

ESC Updates Guidelines for Treating STEMI Patients

CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events

Study Results: Titaniam-nitride-oxide (TiNO) Coated Stent is Non-inferior to Bioabsorbable Polymer Everolimus-eluting Stent (EES), for Patients Presenting with Acute Coronary Syndrome (ACS)

CABG Appears Superior to PCI for Patients With Type 1 Diabetes, Multivessel Disease

Off-Pump CABG Linked to Higher Long-term Mortality in ROOBY-FS

Revascularization in Shock: Does it matter?

When to Use Support for Complete Revascularization

Inotropes and Drug Therapies for Shock: Data and Outcomes

Unprotected Left Main Stenting and Complete Revascularization

The Case for Complete Revascularization

Yes, the Data Favor Invasive Management and Revascularization for These Patients (with Ischemic CM)

Readmissions After Acute MI Not Only Confined to the Elderly

Money-Back Guarantee for Evolocumab Has Little Impact on Cost-Effectiveness

CKD Patients Undergoing PCI Much Less Likely to Receive Potent P2Y12 Inhibition

Registry Confirms Long-term Durability of Drug-Coated Balloon for Femoropopliteal Lesions

‘Remnant’ Cholesterol Linked With CVD Risk, Even When LDL Levels Are Low

Despite the Strengths of Next-Gen DES, BMS Deserve a Place at the Cath Table, Review Asserts

Spectranetics Announces FDA Approval of Stellarex™ Drug-Coated Balloon

Spectranetics Announces FDA Approval of Stellarex™ Drug-Coated Balloon

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content